ADLAI NORTYE
Adlai Nortye is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with its R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, it has built a global pipeline through collaborations and internal discoveries with more than 10 drug candidates in development.
ADLAI NORTYE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.en.adlainortye.com
Total Employee:
51+
Status:
Active
Contact:
+86 571 2891 8366
Email Addresses:
[email protected]
Total Funding:
253 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Nginx Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Legend Star
Legend Star investment in Series D - Adlai Nortye
Tiange Interactive Holdings
Tiange Interactive Holdings investment in Series D - Adlai Nortye
Guolian Securities
Guolian Securities investment in Series D - Adlai Nortye
TriWise Capital
TriWise Capital investment in Series D - Adlai Nortye
SDIC Fund Management
SDIC Fund Management investment in Series D - Adlai Nortye
WuXi Healthcare Ventures
WuXi Healthcare Ventures investment in Series D - Adlai Nortye
Tigermed
Tigermed investment in Series D - Adlai Nortye
ICBC Asset Management
ICBC Asset Management investment in Series C - Adlai Nortye
Tigermed
Tigermed investment in Series C - Adlai Nortye
Yingke Capital
Yingke Capital investment in Series C - Adlai Nortye
Official Site Inspections
http://www.en.adlainortye.com
Unable to get host informations!!!
